Cryoport stock rises on Q2 2026 earnings and guidance
Published on 09/19/2026 at 16:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCryoport, Inc. (ISIN US2289031005) stock closed at USD 17.02 on September 18, 2026, after adding 1.43 percent, with market capitalization at USD 862.06 million and volume at 856,796 shares. MarketBeat also shows a 52-week range of USD 7.61 to USD 17.20, leaving the shares close to the top of that band.
Q2 figures still matter
According to MarketBeat, Cryoport reported Q2 2026 revenue of USD 48.97 million and EPS of minus USD 0.20 on August 6, 2026. The same page says analysts expected minus USD 0.19 per share, so the company missed by USD 0.01.
MarketBeat also lists Q2 2026 net margin at minus 20.05 percent and return on equity at minus 7.20 percent. For investors, that keeps the focus on whether Cryoport can turn its revenue base into better operating leverage.
Guidance and targets
MarketBeat says Cryoport affirmed 2026 revenue guidance of USD 192 million to USD 196 million in the August 8, 2026 coverage it tracks, and the same page shows a consensus price target of USD 18.00 versus a last close of USD 17.02. That implies only limited upside from the current quote.
The stock is also trading above its 2026 starting point of USD 9.60, and MarketBeat says it has gained 77.3 percent since then. A first.
Stock near its high
With USD 17.02 on September 18, 2026, Cryoport stock is sitting just below the 52-week high of USD 17.20 and well above the 52-week low of USD 7.61. The market value of USD 862.06 million and the volume of 856,796 shares show a stock that is active and valued on its recovery path.
Cryoport stock at a glance
- Company: Cryoport, Inc.
- ISIN: US2289031005
- Ticker: CYRX
- Trading venue: NASDAQ
- Price (as of September 18, 2026): USD 17.02
- Market capitalization: USD 862.06 million (as of September 18, 2026)
- Sector / Industry: Healthcare / Life Sciences Tools & Services
- Index membership: Not stated in the available sources
